Abstract
BackgroundThe therapeutic strategy for children with cow’s milk allergy (CMA) consists in the elimination of cow’s milk (CM) from their diet. Donkey’s milk (DM) has been reported to be an adequate alternative, mainly to his nutritional similarities with human milk (HM) and excellent palatability. The aim of present prospective study was to evaluate the nutritional impact of DM on the diet of children with CMA in term of children growth.MethodsBefore the nutritional trial on children and during the study the health and hygiene risks and nutritional and nutraceuticals parameters of DM were monitored. Children with CMA were identified by the execution of in vivo and in vitro tests for CM and subsequent assessment of tolerability of DM with oral food challenge (OFC). Finally, we prescribed DM to a selected group of patients for a period of 6 months during which we monitored the growth of children. A total of 81 children, 70 with IgE mediated cow’s milk protein allergy (IgE-CMPA) and 11 with Food Protein Induced Enterocolitis Syndrome to CM (CM-FPIES), were enrolled.ResultsSeventy-eight out of 81 patients underwent the OFC with DM and only one patient with IgE-CMPA (1.5 %) reacted. Twenty-two out of 81 patients took part of the nutritional trial. All the 22 patients took and tolerated the DM, moreover DM did not change the normal growth rate of infants.ConclusionsIn conclusion, DM resulted safe in term of health and hygiene risks and nutritionally adequate: no negative impact on the normal growth rate of children was assessed. Therefore, it may be a suitable alternative for the management of IgE mediated CMA and FPIES, also in the first 6 months of life, if adequately supplemented.
Highlights
The therapeutic strategy for children with cow’s milk allergy (CMA) consists in the elimination of cow’s milk (CM) from their diet
Cow’s milk (CM) based formulas are widely used as a substitute for human milk (HM), 2–3% of children present an IgE-mediated cow’s milk protein allergy (IgE- IgE-mediate cow’s milk protein allergy (CMPA)) [2, 3] and it is known that in the 0.34% of children, CM can cause the Food Protein Induced Enterocolitis Syndrome (CM-FPIES) [4]
The main purpose of this study is to evaluate the nutritional impact of Donkey’s milk (DM), appropriately integrated, on the diet of patients with IgE-CMPA and CM-FPIES in terms of children’s growth
Summary
The therapeutic strategy for children with cow’s milk allergy (CMA) consists in the elimination of cow’s milk (CM) from their diet. Donkey’s milk (DM) has been reported to be an adequate alternative, mainly to his nutritional similarities with human milk (HM) and excellent palatability. Cow’s milk (CM) based formulas are widely used as a substitute for HM, 2–3% of children present an IgE-mediated cow’s milk protein allergy (IgE- CMPA) [2, 3] and it is known that in the 0.34% of children, CM can cause the Food Protein Induced Enterocolitis Syndrome (CM-FPIES) [4]. The therapeutic strategy for children with IgE-CMPA or CM-FPIES consists of the total elimination of cow’s milk protein (CMP) from their diet [4, 5, 7]. EHFs and FAAFs are hampered by their unpleasant taste related
Sign-in/Register to view highlights & summary 
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call